Tara Bancroft
Stock Analyst at TD Cowen
(2.58)
# 2,239
Out of 4,761 analysts
8
Total ratings
50%
Success rate
20.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $30.88 | +61.92% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $38.75 | +67.74% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $7.00 | +57.14% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $2.57 | +289.11% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $47.37 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $11.66 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $30.88
Upside: +61.92%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $38.75
Upside: +67.74%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $7.00
Upside: +57.14%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $2.57
Upside: +289.11%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $47.37
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $11.66
Upside: -